Key result
Radiotherapy-sparing strategy in pediatric synovial sarcoma yields ~85% five-year overall survival.
Why the study?
It was unclear if modified indications of radiotherapy or radical surgery compromised survival in pediatric localized synovial sarcoma.
Does a sparing strategy omitting radiotherapy compromise survival in children with non-metastatic synovial sarcoma?
Cohort (n=88)
Yes
Does a sparing strategy omitting radiotherapy compromise survival in children with non-metastatic synovial sarcoma?
A sparing strategy omitting radiotherapy in selected pediatric patients with localized synovial sarcoma achieves 5-year overall survival of 85%, comparable to published data.
Answers are grounded in this paper and cite their sources.
Supports selective radiotherapy sparing in pediatric synovial sarcoma; hypothesis-generating and requires prospective validation before practice change.
BACKGROUND: The aim of this analysis was to identify if the modified indications of radiotherapy (RT) or radical surgery compromised survival in pediatric synovial sarcoma (SS). PROCEDURE: Children with non-metastatic SS, prospectively enrolled in three trials, were analyzed. After primary surgery or biopsy, they received chemotherapy. RT was planned after chemotherapy in patients who had not achieved a complete response (CR). The considered outcome was 5-year overall survival (OS) and event-free survival (EFS). RESULTS: Eighty-eight patients were identified. Primary tumors were mainly located in limbs (66%). The first-line therapy for 65 patients was primary resection. Of the 49 patients who had gross tumor resection, 43 received adjuvant chemotherapy, and 8 had RT. All of the 39 patients with macroscopic residual disease received chemotherapy, then only surgery (n = 12) ± RT (n = 22). The 5-year EFS and OS rates were 68% and 85%, respectively. The TNM stage was a prognostic factor for relapse, whereas primary site of the tumor and TNM stage were prognostic factors for death. CONCLUSIONS: Only 32% of survivors received RT. OS was similar to published data. Omission of RT may be considered in younger children, to limit the potential sequelae in patients with tumors less than 5 cm in size initially submitted to marginal resection. This strategy may also be considered in initially unresected cases, when the tumor is resected at delayed surgery with microscopically free margins, and in patients in complete remission after primary chemotherapy.
No takes yet. Share an insight, caveat, or question.
Orbach et al. (2011) conducted a cohort in Pediatric localized synovial sarcoma (n=88). Radiotherapy-sparing strategy was evaluated on 5-year overall survival (OS) and event-free survival (EFS). A radiotherapy-sparing strategy in pediatric localized synovial sarcoma resulted in 5-year event-free and overall survival rates of 68% and 85%, respectively, with only 32% receiving radiotherapy.
Synapse has enriched 10 related papers. Consider them for comparative context: